The GBA1 gene, located on chromosome 1q21, encodes the lysosomal enzyme glucocerebrosidase (GCase), which is crucial for the breakdown of glucocerebroside into glucose and ceramide. Mutations in GBA1 are most commonly associated with Gaucher disease, a lysosomal storage disorder characterized by the accumulation of glucocerebroside in macrophages, leading to hepatosplenomegaly, anemia, and bone abnormalities (Sidransky et al., 2009). Beyond Gaucher disease, GBA1 mutations are a significant genetic risk factor for Parkinson's disease (PD) and related synucleinopathies. Studies suggest that impaired GCase activity contributes to the accumulation of alpha-synuclein, a hallmark of PD pathology (Alcalay et al., 2012). The GBA1 gene has over 400 known mutations, with varying impacts on enzyme activity and disease severity. Research continues to explore the mechanisms linking GBA1 dysfunction to neurodegenerative diseases, offering potential therapeutic targets.